News

Vulnerable populations are more at risk to suffer from food insufficiency or insecurity.

The SOLOIST-WHF trial indicates that SGLT2 inhibition may lead to an overall reduction in cardiovascular-related deaths and hospitalizations.

Primate model studies show the procedure can be done safely and without losing eye function. Which patients may benefit first?

The recommendations address issues related to vaccinator and patient education, counseling, billing, and reimbursement.

A new study finds benefit to hemoglobin A1c reductions made following conception.

A conversation on how associations between the chronic conditions have become better understood in 10 years.

Researchers suggest bolstering beneficial gut species depleted in COVID-19 could mitigate severe disease.

Primary care physicians should be aware of which patients are at high risk for developing glaucoma.

It’s possible that C diff could be a marker for frailty in geriatric patients.

The current literature points to the potential efficacy and safety of the anti-depressant drug, but more research is needed to verify its role in managing pain caused by vaso-occlusive crises.

The study finds that individuals with mothers who had pregestational diabetes had a 2.3-fold increased risk of MS compared to those with non-diabetic mothers.

China has overtaken the US and is currently leading all countries in total vaccine administrations.

Obese or overweight men participating in a lifestyle-based program had lower rates of diabetes after 2 years when also given testosterone therapy, a new study finds.

The negative effects of the pandemic may disrupt efforts to eradicate HBV as a public health threat by 2030.

Dr. Rakesh Jetly is leading a new phase 2 study testing psychedelics in veterans with PTSD.

Alnylam plans to submit a NDA for the orphan drug used to treat hATTR with amyloidosis in adults.

New one-year data makes history as the first to indicate the superiority of a one-injection gene therapy versus Factor VIII prophylaxis.

A discussion around obesity's effect on asthma, and the newest recommendations for managed care.

Peter Lio, MD talks about the promise and risks of cannabinoids as potential treatment for itch.

Using piperacillin/tazobactam increases the risk for acute kidney injury, and this risk can be exacerbated by concurrent vancomycin.

If approved, the treatment would be the first SGLT2 inhibitor for patients with chronic kidney disease.

In vitro data suggest the more transmissible mutations of the virus are nonetheless prevented by the mRNA vaccine.

Researchers will soon test psychosubstances as a potential treatment for veterans with PTSD.

Peter Lio, MD, discusses a few surprising therapies for pruritus that show some promise.

Adolescent delinquency and perceived classmate drug use were linked to adolescent opioid misuse.

Few studies have used semiobjective tests to assess olfactory dysfunction and its association with COVID-19.

In nearly 1.9 million doses of the COVID-19 vaccine there has been only 21 total cases of anaphylaxis.

A seven-question quiz comparing the respiratory viruses. Can you pass it?